Avid Bioservices, Inc. (CDMO)
Feb 5, 2025 - CDMO was delisted (reason: acquired by GHO & Ampersand)
12.49
0.00 (0.00%)
Inactive · Last trade price on Feb 4, 2025

Avid Bioservices Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Avid Bioservices stock had an average target of $12.25, with a low estimate of $12 and a high estimate of $12.5.

Price Target: $12.25 (-1.92%)
Analyst Consensus: Hold

Price Target

TargetLowAverageMedianHigh
Price$12$12.25n/a$12.5
Change-3.92%-1.92%n/a+0.08%

Analyst Ratings

The average analyst rating for Avid Bioservices stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
166.37M
from 139.91M
Increased by 18.91%
Revenue Next Year
194.26M
from 166.37M
Increased by 16.76%
EPS This Year
-0.34
from -2.23
EPS Next Year
-0.06
from -0.34
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingApr 30, 2020Apr 30, 2021Apr 30, 2022Apr 30, 2023Apr 30, 2024Apr 30, 2025Apr 30, 2026
Revenue
59.70M95.87M119.60M149.27M139.91M166.37M194.26M
Revenue Growth
11.38%60.58%24.75%24.81%-6.27%18.91%16.76%
EPS
-0.270.061.840.00-2.23-0.34-0.06
No. Analysts
-----77

Revenue Forecast

Revenue20252026202720282029
High172.3M206.0M
Avg166.4M194.3M
Low159.0M180.9M

Revenue Growth

Revenue Growth20252026202720282029
High
23.1%
23.8%
Avg
18.9%
16.8%
Low
13.6%
8.7%

EPS Forecast

EPS202520262027
High-0.260.12
Avg-0.34-0.06
Low-0.40-0.21

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--